Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2014
05/13/2014US8722661 Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase
05/13/2014US8722578 Spiroheterocyclic pyrrolidinedione herbicidal compositions
05/13/2014US8722209 Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element
05/13/2014CA2758144C Cyclic compound having substituted phenyl group
05/13/2014CA2647208C Glucokinase activators
05/13/2014CA2631654C [(1h-indol-5-yl)-heteroaryloxy]-(1-aza-bicyclo[3.3.1]nonanes as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenrative disorders
05/13/2014CA2623721C Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists
05/13/2014CA2618524C Pyrazole derivatives having tyrosine kinase activity
05/13/2014CA2559733C Inhibitors of histone deacetylase
05/13/2014CA2559408C Carboline derivatives useful in the inhibition of angiogenesis
05/13/2014CA2520855C Imidazopyridine derivatives as melanocortin receptor agonists
05/08/2014WO2014071044A1 Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
05/08/2014WO2014070976A1 Inhibitors of cytomegalovirus
05/08/2014WO2014069510A1 Novel amine derivative or salt thereof
05/08/2014WO2014069434A1 Novel thiazolidinone derivative
05/08/2014WO2014069426A1 Benzimidazole having ampk activating effect and azabenzimidazole derivative
05/08/2014WO2014069351A1 Method for producing optically active bicyclic urea compound
05/08/2014WO2014068988A1 Pyrazolopyridine derivatives as ttx-s blockers
05/08/2014WO2014068104A1 Hydroxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use as soluble guanylate cyclase stimulants
05/08/2014WO2014068099A1 Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
05/08/2014WO2014068095A1 Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use as soluble guanylate cyclase stimulants
05/08/2014WO2014028589A3 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
05/08/2014WO2012149280A3 Novel tricyclic compounds
05/08/2014US20140128610 R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial
05/08/2014US20140128609 Pyrroloquinoline quinone disodium salt crystal and method for producing the same
05/08/2014US20140128600 Methods for preparing naphthyridines
05/08/2014US20140128426 Antiviral Drugs for Treatment of Arenavirus Infection
05/08/2014US20140128425 Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
05/08/2014US20140128424 Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
05/08/2014US20140128400 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
05/08/2014US20140128391 Selective hdac1 and hdac2 inhibitors
05/08/2014US20140128389 Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
05/08/2014US20140128386 Hydroxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
05/08/2014US20140128385 Bace-2 inhibitors for the treatment of metabolic disorders
05/08/2014US20140128382 5-substituted iminothiazines and their mono- and dioxides as bace inhibitors, compositions, and their use
05/08/2014US20140128375 Benzazepine compounds as cgrp receptor antagonists
05/08/2014US20140128374 Heteroaromatic compounds and their use as dopamine d1 ligands
05/08/2014US20140128373 Compounds and methods for kinase modulation, and indications therefor
05/08/2014US20140128372 Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
05/08/2014US20140128370 Tetrahydro-Pyrido-Pyrimidine Derivatives
05/08/2014US20140128365 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
05/07/2014EP2728639A1 Organic electroluminescent element
05/07/2014EP2727920A1 1,5-naphthyridine derivative or salt thereof
05/07/2014EP2727917A1 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
05/07/2014EP2727915A1 Synthesis of deuterated catechols and benzo[d][1,3]dioxoles and derivatives thereof
05/07/2014EP2726479A1 Novel inhibitor compounds of phosphodiesterase type 10a
05/07/2014EP2726466A1 Fused benzoxazepinones as ion channel modulators
05/07/2014CN103781787A 含氮化合物及其用途 Nitrogen-containing compounds and use thereof
05/07/2014CN103781786A 具有ampk活化作用的氮杂苯并咪唑衍生物 Aza-benzimidazole derivatives having an activating effect ampk
05/07/2014CN103781785A 作为α2肾上腺素能受体的调节剂的N-(咪唑烷-2-亚基)-杂环戊并[b]吡啶衍生物 As α2 adrenergic receptor modulators N- (imidazol-2-ylidene) - heterocyclopentadienyl and [b] pyridine derivatives
05/07/2014CN103781768A Pde10调节剂 Pde10 moderator
05/07/2014CN103773360A 一种希夫碱荧光聚合物及其制备方法 One kind of fluorescent polymer Schiff base and its preparation method
05/07/2014CN103772391A 一类治疗房角狭窄的化合物及其用途 Angle narrow class of therapeutic compounds and their uses
05/07/2014CN103772388A 鹰爪豆碱衍生物的盐 Salt sparteine ​​derivatives
05/07/2014CN103772387A 苦豆碱衍生物的盐 Salt aloperine Derivatives
05/07/2014CN103772386A 一种可提高金雀花碱提取度的原料预处理方法 A feedstock pretreatment method can improve the degree of extraction of cytisine
05/07/2014CN103772385A 一种可提高金雀花碱提取度的原料预处理方法 A feedstock pretreatment method can improve the degree of extraction of cytisine
05/07/2014CN103772384A 一种制备他达拉非的方法 A process for the preparation of tadalafil
05/07/2014CN103772383A 吴茱萸碱衍生物的盐 Salt Evodiamine Derivatives
05/07/2014CN103772382A 一种6-溴-8-羟基-咪唑并(1,2a)吡啶盐酸盐及其合成方法 One kind of 6-bromo-8-hydroxy - imidazo (1,2a) pyridine hydrochloride and the synthesis of
05/07/2014CN103772381A 一种四稠环喹啉类化合物及其制备方法 A four-fused ring quinoline compounds and methods
05/07/2014CN103772380A 一类治疗房角狭窄的化合物及其用途 Angle narrow class of therapeutic compounds and their uses
05/07/2014CN103772120A 新颖的有机电致发光化合物和使用该化合物的有机电致发光设备 Novel organic electroluminescent compounds and the use of the compound organic electroluminescent devices
05/07/2014CN102341388B 作为γ分泌酶调节剂的取代苯并*唑、苯并咪唑、*唑并吡啶和咪唑并吡啶衍生物 As the γ-secretase modulators substituted benzo * indazole, benzimidazole, oxazole, and pyridine and imidazole * pyridine derivative
05/07/2014CN102146084B 3-氰基-6-氨基喹啉类衍生物、其制备方法及其在医药上的应用 3-cyano-6-amino-quinoline derivatives, their preparation and their applications in medicine
05/07/2014CN102036989B 6-杂芳基咪唑并[1,2-a]吡啶的多取代衍生物及其制备方法和治疗用途 6- heteroaryl imidazo [1,2-a] pyridine derivatives and polysubstituted preparation and therapeutic use
05/07/2014CN102026972B 螺[环烷基-1,3′-吲哚]-2′(1′H)-酮的取代衍生物及其作为p38促分裂原活化蛋白激酶抑制剂的应用 Spiro [cycloalkyl-1,3'-indol] -2 '(1'H) - one and its substituted derivatives as p38 mitogen-activated protein kinase inhibitors Applications
05/07/2014CN101186608B 咪唑并吡啶基化合物及含其的有机层的有机发光二极管 Imidazopyridine-based compound and an organic light emitting diode of the organic layer containing it
05/06/2014US8716524 Optically active quaternary ammonium salt having axial asymmetry and process for producing a-amino acid and derivative thereof with the same
05/06/2014US8716493 Multicyclic compounds and the use thereof
05/06/2014US8716479 Methods for stereoselective reduction
05/06/2014US8716475 2-aminopyrimidine modulators of the histamine H4 receptor
05/06/2014US8716323 Cyclic protein tyrosine kinase inhibitors
05/06/2014US8716308 (1-azinone)-substituted pyridoindoles
05/06/2014US8716278 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
05/06/2014US8716274 Heteroaryl pyridone and aza-pyridone compounds
05/06/2014US8716273 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy
05/06/2014US8716272 N-(amino-heteroaryI)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy
05/06/2014CA2508165C Pyridines for treating injured mammalian nerve tissue
05/01/2014WO2014066772A1 Processes and reagents for making diaryliodonium salts
05/01/2014WO2014066318A1 Combination therapies for the treatment of alzheimer's disease and related disorders
05/01/2014WO2014065215A1 Transparent electrode, electronic device, and organic electroluminescent element
05/01/2014WO2014065190A1 Rare earth complex and application for same
05/01/2014WO2014065189A1 Rare earth complex and application for same
05/01/2014WO2014064134A1 3,4-disubstituted 1 h-pyrazole and 4,5-disubstituted thiazole inhibitors of syk
05/01/2014WO2014063778A1 2-aminopyridine compounds
05/01/2014WO2014063659A1 Treatment of cancer using a smad3 inhibitor
05/01/2014WO2013149121A8 1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE β-LACTAMASE INHIBITORS
05/01/2014US20140121367 Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds
05/01/2014US20140121336 Method for increasing production volume of fine particles using forced thin film fluid treatment apparatus
05/01/2014US20140121236 Compositions and Methods for Treating Myotonic Dystrophy Type 1
05/01/2014US20140121219 New Compounds I
05/01/2014US20140121212 Pyrido[2,3-b]pyrazin-8-substituted Compounds and Their Use
05/01/2014US20140121204 Novel dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders.
05/01/2014US20140121203 IMIDAZO[1,2-a]PYRIDINE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS
05/01/2014US20140121200 Substituted pyridopyrazines as novel syk inhibitors
05/01/2014US20140121194 Method for administering agent for controlling ectoparasite to dog
05/01/2014US20140120087 Triazolopyridines
05/01/2014US20140120083 Treatment of cancers using pi3 kinase isoform modulators
04/2014
04/30/2014EP2725028A1 Substituted pyrazolo[1,5-]pyrimidine compounds as intermediates in the synthesis of TRK kinase inhibitors
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 646